Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Intestinal enzyme activity" is not a specific molecule or receptor but rather refers to the collective action of various digestive enzymes produced and active in the small intestine. These include both brush border enzymes—such as lactase, maltase, sucrase, and peptidases—produced by enterocytes lining the intestinal wall, and pancreatic enzymes—such as amylase, lipase, trypsinogen/trypsin—that are secreted into the intestinal lumen via the pancreas. These enzymes catalyze the breakdown of complex carbohydrates into simple sugars (e.g., maltose to glucose by maltase), proteins into amino acids (by peptidases), and fats into fatty acids and glycerol (by lipases). Proper function is essential for nutrient absorption; deficiencies or dysfunction can result in malabsorption syndromes such as lactose intolerance or exocrine pancreatic insufficiency. "Intestinal enzyme activity" is therefore a physiological process rather than a discrete therapeutic target or molecular entity.[1][3][5][7]
Enzymatic hydrolysis of macronutrients into absorbable monomers[1][5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal digestive enzyme.